Biocorp Production

Biocorp Production ROA

Delisted

The Return on Assets (ROA) of Biocorp Production (ALCOR.PA) as of Oct 26, 2026 is -5.17 %. In the previous year, Return on Assets (ROA) was 2.76 % — a change of -287.38% (lower).

ROA

-5.17 %

YoY

-287.38%

Last updated:

In 2022, Biocorp Production's return on assets (ROA) was -5.17 %, a -287.38% increase from the 2.76 % ROA in the previous year.

The Biocorp Production ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2015
-7.09 EUR
Jan 1, 2016
-41.33 EUR
Jan 1, 2017
-142.66 EUR
Jan 1, 2018
-104.42 EUR
Jan 1, 2019
14.17 EUR
Jan 1, 2020
-10.61 EUR
Jan 1, 2021
2.76 EUR
Jan 1, 2022
-5.17 EUR
The Biocorp Production ROA history
YEARROAYoY
-5.17 %-287.38%
2.76 %-126.03%
-10.61 %-174.88%
14.17 %-113.57%
-104.42 %-26.81%
-142.66 %+245.14%
-41.33 %+482.63%
-7.09 %-12,261.42%
0.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biocorp Production Stock analysis

What does Biocorp Production do? Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production is one of the most popular companies on Eulerpool.

ROA Details

Understanding Biocorp Production's Return on Assets (ROA)

Biocorp Production's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Biocorp Production's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Biocorp Production's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Biocorp Production’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Biocorp Production stock

Return on Assets (ROA) of Biocorp Production is -5.17 % in 2022.

Return on Assets (ROA) of Biocorp Production changed from 2.76 % to -5.17 %, representing a -287.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Biocorp Production since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Biocorp Production with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biocorp Production

All Key Metrics — Biocorp Production